ID   HCD2_HUMAN              Reviewed;         261 AA.
AC   Q99714; Q5H927; Q8TCV9; Q96HD5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   21-MAR-2012, entry version 139.
DE   RecName: Full=3-hydroxyacyl-CoA dehydrogenase type-2;
DE            EC=1.1.1.35;
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase 10;
DE            Short=17-beta-HSD 10;
DE   AltName: Full=3-hydroxy-2-methylbutyryl-CoA dehydrogenase;
DE            EC=1.1.1.178;
DE   AltName: Full=3-hydroxyacyl-CoA dehydrogenase type II;
DE   AltName: Full=Endoplasmic reticulum-associated amyloid beta-peptide-binding protein;
DE   AltName: Full=Mitochondrial ribonuclease P protein 2;
DE            Short=Mitochondrial RNase P protein 2;
DE   AltName: Full=Short-chain type dehydrogenase/reductase XH98G2;
DE   AltName: Full=Type II HADH;
GN   Name=HSD17B10; Synonyms=ERAB, HADH2, MRPP2, SCHAD, XH98G2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=97478528; PubMed=9338779; DOI=10.1038/39522;
RA   Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F.,
RA   Collinson K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S.,
RA   Roher A., Stern D.;
RT   "An intracellular protein that binds amyloid-beta peptide and mediates
RT   neurotoxicity in Alzheimer's disease.";
RL   Nature 389:689-695(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zhuchenko O.P., Wehnert M., Bailey J., Sun Z.S., Lee C.C.;
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=98337980; PubMed=9671743; DOI=10.1073/pnas.95.15.8709;
RA   Miller A.P., Willard H.F.;
RT   "Chromosomal basis of X chromosome inactivation: identification of a
RT   multigene domain in Xp11.21-p11.22 that escapes X inactivation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8709-8714(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=98221216; PubMed=9553139; DOI=10.1074/jbc.273.17.10741;
RA   He X.Y., Schulz H., Yang S.Y.;
RT   "A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical
RT   to an amyloid beta-peptide-binding protein involved in Alzheimer's
RT   disease.";
RL   J. Biol. Chem. 273:10741-10746(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 51-246.
RA   Deininger M.H., Meyermann R., Schluesener H.J.;
RT   "Expression, release and induction of endoplasmic reticulum-associated
RT   amyloid beta-binding protein in brain disease.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   INVOLVEMENT IN MRXS10.
RX   PubMed=17236142; DOI=10.1086/511527;
RA   Lenski C., Kooy R.F., Reyniers E., Loessner D., Wanders R.J.A.,
RA   Winnepenninckx B., Hellebrand H., Engert S., Schwartz C.E., Meindl A.,
RA   Ramser J.;
RT   "The reduced expression of the HADH2 protein causes X-linked mental
RT   retardation, choreoathetosis, and abnormal behavior.";
RL   Am. J. Hum. Genet. 80:372-377(2007).
RN   [10]
RP   INVOLVEMENT IN MRX17.
RX   PubMed=18252223; DOI=10.1016/j.ajhg.2007.11.002;
RA   Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O.,
RA   Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H.,
RA   Chelly J., Sanlaville D., van Bokhoven H., Ropers H.-H.,
RA   Laumonnier F., Ranieri E., Schwartz C.E., Abidi F., Tarpey P.S.,
RA   Futreal P.A., Whibley A., Raymond F.L., Stratton M.R., Fryns J.-P.,
RA   Scott R., Peippo M., Sipponen M., Partington M., Mowat D., Field M.,
RA   Hackett A., Marynen P., Turner G., Gecz J.;
RT   "Submicroscopic duplications of the hydroxysteroid dehydrogenase
RT   HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental
RT   retardation.";
RL   Am. J. Hum. Genet. 82:432-443(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH
RP   KIAA0391 AND RG9MTD1, AND SUBCELLULAR LOCATION.
RX   PubMed=18984158; DOI=10.1016/j.cell.2008.09.013;
RA   Holzmann J., Frank P., Loeffler E., Bennett K.L., Gerner C.,
RA   Rossmanith W.;
RT   "RNase P without RNA: identification and functional reconstitution of
RT   the human mitochondrial tRNA processing enzyme.";
RL   Cell 135:462-474(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH NAD.
RX   PubMed=15342248; DOI=10.1016/j.jmb.2004.07.071;
RA   Kissinger C.R., Rejto P.A., Pelletier L.A., Thomson J.A.,
RA   Showalter R.E., Abreo M.A., Agree C.S., Margosiak S., Meng J.J.,
RA   Aust R.M., Vanderpool D., Li B., Tempczyk-Russell A.,
RA   Villafranca J.E.;
RT   "Crystal structure of human ABAD/HSD10 with a bound inhibitor:
RT   implications for design of Alzheimer's disease therapeutics.";
RL   J. Mol. Biol. 342:943-952(2004).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=15087549; DOI=10.1126/science.1091230;
RA   Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N.,
RA   Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S.,
RA   Gunn-Moore F., Lue L.-F., Walker D.G., Kuppusamy P., Zewier Z.L.,
RA   Arancio O., Stern D., Yan S.-S., Wu H.;
RT   "ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's
RT   disease.";
RL   Science 304:448-452(2004).
RN   [16]
RP   VARIANTS MHBD DEFICIENCY VAL-122 AND CYS-130.
RX   MEDLINE=22589980; PubMed=12696021; DOI=10.1086/375116;
RA   Ofman R., Ruiter J.P.N., Feenstra M., Duran M., Poll-The B.T.,
RA   Zschocke J., Ensenauer R., Lehnert W., Sass J.O., Sperl W.,
RA   Wanders R.J.A.;
RT   "2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by
RT   mutations in the HADH2 gene.";
RL   Am. J. Hum. Genet. 72:1300-1307(2003).
RN   [17]
RP   VARIANTS MHBD DEFICIENCY CYS-130 AND SER-247, AND CHARACTERIZATION OF
RP   VARIANT MHBD DEFICIENCY SER-247.
RX   PubMed=16148061; DOI=10.1203/01.pdr.0000176916.94328.cd;
RA   Perez-Cerda C., Garcia-Villoria J., Ofman R., Sala P.R., Merinero B.,
RA   Ramos J., Garcia-Silva M.T., Beseler B., Dalmau J., Wanders R.J.A.,
RA   Ugarte M., Ribes A.;
RT   "2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-
RT   linked inborn error of isoleucine metabolism that may mimic a
RT   mitochondrial disease.";
RL   Pediatr. Res. 58:488-491(2005).
RN   [18]
RP   ERRATUM.
RA   Perez-Cerda C., Garcia-Villoria J., Ofman R., Sala P.R., Merinero B.,
RA   Ramos J., Garcia-Silva M.T., Beseler B., Dalmau J., Wanders R.J.,
RA   Ugarte M., Ribes A.;
RL   Pediatr. Res. 59:162-162(2006).
CC   -!- FUNCTION: Functions in mitochondrial tRNA maturation. Part of
CC       mitochondrial ribonuclease P, an enzyme composed of MRPP1/RG9MTD1,
CC       MRPP2/HSD17B10 and MRPP3/KIAA0391, which cleaves tRNA molecules in
CC       their 5'-ends. By interacting with intracellular amyloid-beta, it
CC       may contribute to the neuronal dysfunction associated with
CC       Alzheimer disease (AD).
CC   -!- CATALYTIC ACTIVITY: (S)-3-hydroxyacyl-CoA + NAD(+) = 3-oxoacyl-CoA
CC       + NADH.
CC   -!- CATALYTIC ACTIVITY: (2S,3S)-3-hydroxy-2-methylbutanoyl-CoA +
CC       NAD(+) = 2-methylacetoacetyl-CoA + NADH.
CC   -!- SUBUNIT: Homotetramer (By similarity). Interacts with
CC       MRPP1/RG9MTD1 and MRPP3/KIAA0391.
CC   -!- INTERACTION:
CC       P05067:APP; NbExp=4; IntAct=EBI-79964, EBI-77613;
CC       Q7L0Y3:RG9MTD1; NbExp=4; IntAct=EBI-79964, EBI-2107046;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99714-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99714-2; Sequence=VSP_007830;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Expressed in normal tissues but is
CC       overexpressed in neurons affected in AD.
CC   -!- DISEASE: Defects in HSD17B10 are the cause of 2-methyl-3-
CC       hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency)
CC       [MIM:300438]. MHBD deficiency leads to neurological abnormalities,
CC       including psychomotor retardation, and, in virtually all patients,
CC       loss of mental and motor skills.
CC   -!- DISEASE: Defects in HSD17B10 are the cause of mental retardation
CC       syndromic X-linked type 10 (MRXS10) [MIM:300220]. MRXS10 is
CC       characterized by mild mental retardation, choreoathetosis and
CC       abnormal behavior.
CC   -!- DISEASE: A chromosomal microduplication involving HSD17B10 and
CC       HUWE1 is the cause of mental retardation X-linked type 17 (MRX17)
CC       [MIM:300705]; also known as mental retardation X-linked type 31
CC       (MRX31). Mental retardation is characterized by significantly sub-
CC       average general intellectual functioning associated with
CC       impairments in adaptative behavior and manifested during the
CC       developmental period. In contrast to syndromic or specific X-
CC       linked mental retardation which also present with associated
CC       physical, neurological and/or psychiatric manifestations,
CC       intellectual deficiency is the only primary symptom of non-
CC       syndromic X-linked mental retardation.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/HSD17B10";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96132; AAC51812.1; -; mRNA.
DR   EMBL; U73514; AAB68958.1; -; mRNA.
DR   EMBL; AF069134; AAC39900.1; -; mRNA.
DR   EMBL; AF035555; AAC15902.1; -; mRNA.
DR   EMBL; AF037438; AAC16419.1; -; Genomic_DNA.
DR   EMBL; Z97054; CAI42652.1; -; Genomic_DNA.
DR   EMBL; CH471154; EAW93158.1; -; Genomic_DNA.
DR   EMBL; BC000372; AAH00372.1; -; mRNA.
DR   EMBL; BC008708; AAH08708.1; -; mRNA.
DR   EMBL; AY092415; AAM18189.1; -; mRNA.
DR   IPI; IPI00017726; -.
DR   IPI; IPI00336094; -.
DR   RefSeq; NP_001032900.1; NM_001037811.2.
DR   RefSeq; NP_004484.1; NM_004493.2.
DR   UniGene; Hs.171280; -.
DR   PDB; 1F67; Model; -; A=1-261.
DR   PDB; 1SO8; X-ray; 2.30 A; A=1-261.
DR   PDB; 1U7T; X-ray; 2.00 A; A/B/C/D=1-261.
DR   PDB; 2O23; X-ray; 1.20 A; A/B=1-261.
DR   PDBsum; 1F67; -.
DR   PDBsum; 1SO8; -.
DR   PDBsum; 1U7T; -.
DR   PDBsum; 2O23; -.
DR   ProteinModelPortal; Q99714; -.
DR   SMR; Q99714; 7-261.
DR   IntAct; Q99714; 10.
DR   MINT; MINT-3059664; -.
DR   STRING; Q99714; -.
DR   PhosphoSite; Q99714; -.
DR   DMDM; 2492759; -.
DR   REPRODUCTION-2DPAGE; IPI00017726; -.
DR   REPRODUCTION-2DPAGE; Q99714; -.
DR   UCD-2DPAGE; Q99714; -.
DR   PeptideAtlas; Q99714; -.
DR   PRIDE; Q99714; -.
DR   DNASU; 3028; -.
DR   Ensembl; ENST00000168216; ENSP00000168216; ENSG00000072506.
DR   GeneID; 3028; -.
DR   KEGG; hsa:3028; -.
DR   UCSC; uc004dsl.1; human.
DR   UCSC; uc004dsm.1; human.
DR   CTD; 3028; -.
DR   GeneCards; GC0XM053475; -.
DR   H-InvDB; HIX0016816; -.
DR   HGNC; HGNC:4800; HSD17B10.
DR   HPA; HPA001432; -.
DR   MIM; 300220; phenotype.
DR   MIM; 300256; gene.
DR   MIM; 300438; phenotype.
DR   MIM; 300705; phenotype.
DR   neXtProt; NX_Q99714; -.
DR   Orphanet; 85295; Intellectual deficit, X-linked - choreoathetosis - abnormal behavior.
DR   Orphanet; 35123; Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
DR   eggNOG; COG1028; -.
DR   GeneTree; ENSGT00640000091086; -.
DR   HOGENOM; HBG750976; -.
DR   HOVERGEN; HBG002145; -.
DR   InParanoid; Q99714; -.
DR   KO; K08683; -.
DR   OMA; AIKTYNL; -.
DR   OrthoDB; EOG46MBKC; -.
DR   PhylomeDB; Q99714; -.
DR   BioCyc; MetaCyc:MONOMER-11801; -.
DR   BRENDA; 1.1.1.135; 908.
DR   Reactome; REACT_111217; Metabolism.
DR   DrugBank; DB00157; NADH.
DR   NextBio; 11984; -.
DR   ArrayExpress; Q5H927; -.
DR   Bgee; Q99714; -.
DR   CleanEx; HS_HSD17B10; -.
DR   Genevestigator; Q99714; -.
DR   GermOnline; ENSG00000072506; Homo sapiens.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0047015; F:3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity; IEA:EC.
DR   GO; GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0008709; F:cholate 7-alpha-dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0009083; P:branched chain family amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0008033; P:tRNA processing; IEA:UniProtKB-KW.
DR   InterPro; IPR002198; DH_sc/Rdtase_SDR.
DR   InterPro; IPR002347; Glc/ribitol_DH.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Chromosomal rearrangement; Complete proteome; Disease mutation;
KW   Mental retardation; Mitochondrion; NAD; Oxidoreductase;
KW   Reference proteome; tRNA processing.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    261       3-hydroxyacyl-CoA dehydrogenase type-2.
FT                                /FTId=PRO_0000054810.
FT   NP_BIND      12     41       NAD.
FT   ACT_SITE    168    168       Proton acceptor.
FT   BINDING     155    155       Substrate.
FT   BINDING     172    172       NAD.
FT   MOD_RES       2      2       N-acetylalanine.
FT   VAR_SEQ     191    199       Missing (in isoform 2).
FT                                /FTId=VSP_007830.
FT   VARIANT     122    122       L -> V (in MHBD deficiency;
FT                                dbSNP:rs28935476).
FT                                /FTId=VAR_015987.
FT   VARIANT     130    130       R -> C (in MHBD deficiency;
FT                                dbSNP:rs28935475).
FT                                /FTId=VAR_015988.
FT   VARIANT     247    247       N -> S (in MHBD deficiency; intermediate
FT                                enzyme activity).
FT                                /FTId=VAR_032093.
FT   STRAND       12     16
FT   TURN         17     19
FT   HELIX        21     32
FT   STRAND       36     41
FT   HELIX        47     53
FT   STRAND       58     62
FT   HELIX        68     82
FT   STRAND       87     89
FT   STRAND      116    118
FT   HELIX       120    137
FT   STRAND      148    153
FT   HELIX       165    168
FT   HELIX       174    186
FT   HELIX       187    189
FT   STRAND      191    197
FT   HELIX       230    242
FT   STRAND      250    252
SQ   SEQUENCE   261 AA;  26923 MW;  9E74F242E3E6FEF1 CRC64;
     MAAACRSVKG LVAVITGGAS GLGLATAERL VGQGASAVLL DLPNSGGEAQ AKKLGNNCVF
     APADVTSEKD VQTALALAKG KFGRVDVAVN CAGIAVASKT YNLKKGQTHT LEDFQRVLDV
     NLMGTFNVIR LVAGEMGQNE PDQGGQRGVI INTASVAAFE GQVGQAAYSA SKGGIVGMTL
     PIARDLAPIG IRVMTIAPGL FGTPLLTSLP EKVCNFLASQ VPFPSRLGDP AEYAHLVQAI
     IENPFLNGEV IRLDGAIRMQ P
//
